Sort
39,280 grants matching “leukemia”
Corepressor regulation of nuclear receptor action
$348,254Anthony N Hollenberg · Beth Israel Deaconess Medical Center · R01 · FY2013 · DK
New Therapeutic Targets in AML
$348,222Jay L. Hess · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
MICRO RNA TARGETING OF NORMAL & LEUKEMIA STEM- PROGENITOR CELLS
$348,133Curt I Civin · Johns Hopkins University · P01 · FY2009 · CA
Targeting SYK Kinase in AML
$348,122Kimberly Stegmaier · Brigham And Women'S Hospital · P50 · FY2018 · CA
Targeting MLL/Menin in AML
$348,122Scott A Armstrong · Brigham And Women'S Hospital · P50 · FY2018 · CA
INTRAMARROW GENE TRANSFER IN NEONATES
$348,093Research Inst Nationwide Children'S Hosp · R01 · FY2001 · AI
Evaluation of self-inactivating lentiviral vectors for treating SCID-X1 patients
$348,064Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2011 · HL
Development of gene therapy for wiskott-aldrich syndrome (WAS)
$348,064Arthur W. Nienhuis · St. Jude Children'S Research Hospital · P01 · FY2011 · HL
CPML - Core B: Cell & Molecular Core
$348,036Kristine R Crews · St. Jude Children'S Research Hospital · P50 · FY2019 · GM
CPML - Core B: Cell & Molecular Core
$348,034Kristine R Crews · St. Jude Children'S Research Hospital · P50 · FY2017 · GM
CPML - Core B: Cell & Molecular Core
$348,034Kristine R Crews · St. Jude Children'S Research Hospital · P50 · FY2016 · GM
Presenilins in tumorigenesis and neurodegeneration
$348,031Baylor College Of Medicine · R01 · FY2004 · NS
Presenilins in tumorigenesis and neurodegeneration
$348,031Baylor College Of Medicine · R01 · FY2005 · NS
Lab-on-a-chip Flow Cytometer Using COlor-Space-Time (COST) Coding Method
$348,000Jose Manuel Morachis · Nanocellect Biomedical, Inc. · R43 · FY2011 · RR
Targeting the Unfolded Protein Response in Leukemia Biology and Chemotherapy Resistance
$347,976Stephen Matthew Sykes · Washington University · R01 · FY2023 · CA
Role of TET proteins in myeloid malignancies
$347,969Anjana Rao · La Jolla Institute For Immunology · R01 · FY2013 · CA
Mechanisms of Nucleocytoplasmic Transport
$347,928Siegfried M Musser · Texas A&M University Health Science Ctr · R01 · FY2010 · GM
The Development of Stat3 Inhibitors
$347,886John S McMurray · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA
Role of TET Proteins in ES Cell Pluripotency and Function
$347,880Anjana Rao · La Jolla Institute For Immunology · R01 · FY2015 · HD
Prevention of quinone toxicity and mutagenicity
$347,879Anil Kumar Jaiswal · Baylor College Of Medicine · R01 · FY2006 · ES
Novel Substrate Competitive Bcr-Abl Inhibitor Active Against Gleevec-Resistant CM
$347,873E Premkumar Reddy · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · HL
Nutrient transport, membrane trfficking, and mTORC1 signaling at lysosomes.
$347,819Michael H. Overholtzer · Sloan-Kettering Inst Can Research · R01 · FY2015 · GM
Role of GLUD2 as a metabolic driver of gliomas with IDH1 mutations
$347,813Hai Yan · Duke University · R01 · FY2017 · NS
Role of GLUD2 as a metabolic driver of gliomas with IDH1 mutations
$347,813Hai Yan · Duke University · R01 · FY2016 · NS
Incorporating FLT3 Inhibitors into AML Treatment Regimens
$347,806Mark J Levis · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA